Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2014 | 09-2014 | 12-2013 | 09-2013 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 2,349 | 2,349 | 2,349 | N/A |
| Receivables | 4,300 | N/A | 0 | N/A | N/A |
| Other current assets | 0 | 0 | 797 | 797 | 0 |
| TOTAL | $4,300 | $3,147 | $3,147 | $3,147 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 0 | 8,010 | 8,010 | 8,010 | N/A |
| Other Non-Current Assets | 0 | 448 | 0 | 0 | 0 |
| TOTAL | $0 | $8,457 | $8,010 | $8,010 | $N/A |
| Total Assets | $4,300 | $11,604 | $11,604 | $11,604 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 726 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 3,101 | 0 | 0 | 0 |
| Accrued Expenses | 0 | 2,560 | 0 | N/A | N/A |
| TOTAL | $0 | $20,210 | $20,210 | $20,210 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 3,653 | 3,653 | 3,653 | N/A |
| Deferred Revenues | 0 | 1,501 | 0 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 17,168 | 3,101 | 3,101 | 0 |
| TOTAL | $0 | $27,167 | $6,754 | $6,754 | $N/A |
| Total Liabilities | $0 | $47,377 | $47,377 | $47,377 | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | 0 | -45,151 | -45,151 | -45,151 | N/A |
| Other shareholders' equity | 10,191 | 9,378 | 9,378 | 9,378 | 0 |
| TOTAL | $10,191 | $-35,773 | $-35,773 | $-35,773 | $N/A |
| Total Liabilities And Equity | $10,191 | $11,604 | $11,604 | $11,604 | $0 |